Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

306
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
306
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

370
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
370
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

403
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
403
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

535
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
535
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

200
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
200
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

176
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
176

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mailed Outreach for Colorectal Cancer Screening in Community Health Centers: The CARES Pragmatic Cluster Randomized Clinical Trial.

JAMA internal medicine·2026
Same author

Food Insecurity and Gastrointestinal Health: Examining Links Between Food Security, Constipation, and Diarrhea in the National Health and Nutrition Examination Survey.

Digestive diseases and sciences·2026
Same author

Balancing Act: Lessons From Comanaging Patients With Inflammatory Bowel Disease and HIV/AIDS.

ACG case reports journal·2026
Same author

Overcoming Persistent Poverty Barriers to Colorectal Cancer Care.

JAMA network open·2026
Same author

Inflammatory Bowel Disease Care Barriers and Medication Beliefs in a Majority Hispanic Population: A Patient Survey.

Crohn's & colitis 360·2025
Same author

Surgical Outcomes in Patients With Inflammatory Bowel Disease and Primary Sclerosing Cholangitis-Related Liver Disease.

ACG case reports journal·2025

Related Experiment Video

Updated: Sep 6, 2025

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
08:58

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis

Published on: January 5, 2017

12.4K

Inflammatory bowel disease in underserved populations: lessons for practice.

Florence-Damilola Odufalu1, Aiya Aboubakr2, Adjoa Anyane-Yeboa3

  • 1Division of GI & Liver Disease, Department of Medicine, Keck School of Medicine of USC, Los Angeles, California.

Current Opinion in Gastroenterology
|June 28, 2022
PubMed
Summary

Inflammatory bowel disease (IBD) is rising in US minority groups, highlighting significant racial and ethnic disparities in care and outcomes. Addressing these inequities requires tackling structural racism and removing barriers to healthcare access.

More Related Videos

Investigating Intestinal Inflammation in DSS-induced Model of IBD
08:43

Investigating Intestinal Inflammation in DSS-induced Model of IBD

Published on: February 1, 2012

67.6K
Performing Colonoscopic-Guided Pinch Biopsies in Mice and Evaluating Subsequent Tissue Changes
08:52

Performing Colonoscopic-Guided Pinch Biopsies in Mice and Evaluating Subsequent Tissue Changes

Published on: February 5, 2021

4.6K

Related Experiment Videos

Last Updated: Sep 6, 2025

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
08:58

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis

Published on: January 5, 2017

12.4K
Investigating Intestinal Inflammation in DSS-induced Model of IBD
08:43

Investigating Intestinal Inflammation in DSS-induced Model of IBD

Published on: February 1, 2012

67.6K
Performing Colonoscopic-Guided Pinch Biopsies in Mice and Evaluating Subsequent Tissue Changes
08:52

Performing Colonoscopic-Guided Pinch Biopsies in Mice and Evaluating Subsequent Tissue Changes

Published on: February 5, 2021

4.6K

Area of Science:

  • Gastroenterology
  • Health Equity
  • Public Health

Background:

  • The incidence of inflammatory bowel disease (IBD) is increasing among minority populations in the United States.
  • Existing research indicates significant racial and ethnic disparities in IBD care and health outcomes.
  • These disparities are linked to historical injustices and social determinants of health.

Purpose of the Study:

  • To review the current literature on racial, ethnic, and sociodemographic disparities in IBD.
  • To identify key areas of inequity in IBD therapeutics and patient outcomes.
  • To explore strategies for achieving health equity in IBD management.

Main Methods:

  • Literature review of current scientific publications.
  • Analysis of data on IBD incidence, therapeutics, and outcomes across different demographic groups.
  • Synthesis of findings to identify patterns of disparity.

Main Results:

  • Racial and ethnic disparities are evident in IBD therapeutics and patient outcomes.
  • These disparities manifest as differences in disease severity, morbidity, and mortality.
  • Sociodemographic factors significantly influence IBD care and prognosis.

Conclusions:

  • Achieving health equity in IBD necessitates addressing structural racism as a fundamental driver of disparities.
  • Multilevel interventions are required to dismantle barriers to equitable IBD care.
  • Actionable strategies must be implemented to improve outcomes for all IBD patients, regardless of race or ethnicity.